Inquiry Basket
Mal-PEG5-NHS is a biomedical product that assumes a pivotal role in drug conjugation and protein modification. Its exceptional reactivity as a linker fosters targeted drug delivery, thereby ramping up therapeutic efficacy to unprecedented levels.
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-00443 | -- | $-- | Inquiry |
Mal-PEG5-NHS is a versatile bioconjugation reagent commonly used in the development of targeted therapies and diagnostic applications. It features a maleimide (Mal) group that allows for selective conjugation with thiol-containing molecules, such as peptides, proteins, or antibodies, and a polyethylene glycol (PEG5) spacer that enhances the solubility, stability, and bioavailability of the conjugate. The NHS (N-hydroxysuccinimide) ester is a reactive functional group that enables efficient coupling to amine groups, making this compound suitable for a wide range of applications in both therapeutic and research settings.
One of the key applications of Mal-PEG5-NHS is in the preparation of antibody-drug conjugates (ADCs) for targeted cancer therapy. The maleimide group allows the compound to conjugate to antibodies that specifically recognize tumor-associated antigens, while the PEG5 spacer improves the solubility and pharmacokinetics of the resulting conjugate. The NHS ester efficiently couples with amine-containing cytotoxic agents or small molecules, facilitating the attachment of potent drugs to the antibody. This targeted approach allows for the precise delivery of chemotherapy agents directly to the tumor, minimizing off-target effects and enhancing the therapeutic index of the treatment.
Mal-PEG5-NHS is also widely used in the design of other drug delivery systems, particularly for the development of peptide-drug conjugates or small molecule conjugates. The PEG5 spacer not only improves solubility and reduces immunogenicity but also ensures that the conjugate remains stable during circulation. The NHS ester is highly reactive with amine-containing drugs, facilitating the efficient attachment of therapeutic agents to the conjugate. This system allows for the controlled release of the drug at the disease site, making it ideal for precision medicine, where treatments can be directed specifically to target tissues such as tumors or infected cells.
In addition to drug delivery, Mal-PEG5-NHS is frequently used in diagnostic applications. It can be employed to conjugate diagnostic antibodies, peptides, or other biomolecules to imaging agents or sensors. The PEG5 spacer ensures that the conjugate maintains solubility and stability in biological environments, which is critical for maintaining effective tissue penetration and signal clarity in imaging studies. The NHS ester enables efficient conjugation to the amine-containing biomolecules, making Mal-PEG5-NHS an excellent choice for molecular imaging, biomarker detection, and diagnostics that require precise targeting of disease sites, such as cancerous tumors or inflammation.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
